AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
Labcorp Holdings Inc.
XNYS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG01MMT6PQ2
314.20▲ 2.23 (0.71%)
As of 2026-10-08
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
311.97
Day's Range
309.04 – 315.48
52-Week Range
244.52 – 341.80
Volume
691.7K
Avg Volume
761.2K
Share Statistics
Shares Outstanding
Employees
71.0K
Exchange
XNYS
Listed
1988-07-07
Share count as of August 4, 2026

Labcorp Holdings Inc. (LH) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Labcorp Holdings Inc. (LH)
What is Labcorp Holdings Inc.'s Market Cap?
Labcorp Holdings Inc.'s Market Cap is $25.5B, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Enterprise Value?
Labcorp Holdings Inc.'s Enterprise Value is $31.3B, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Trailing P/E?
Labcorp Holdings Inc.'s Trailing P/E is 25.4×, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Price / Sales?
Labcorp Holdings Inc.'s Price / Sales is 1.8×, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s EV / Revenue?
Labcorp Holdings Inc.'s EV / Revenue is 2.2×, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s EV / EBITDA?
Labcorp Holdings Inc.'s EV / EBITDA is 14.2×, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Revenue (TTM)?
Labcorp Holdings Inc.'s Revenue (TTM) is $14.3B, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Net Income (TTM)?
Labcorp Holdings Inc.'s Net Income (TTM) is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s EBITDA?
Labcorp Holdings Inc.'s EBITDA is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Diluted EPS (TTM)?
Labcorp Holdings Inc.'s Diluted EPS (TTM) is 12.36, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · LHAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
YoY growth+5.8%+5.8%+5.6%+8.6%
Cost of revenues
Gross profit
% of revenue29.8%28.7%28.2%28.8%
Selling, general, and administrative expenses
Amortization of intangibles and other assets
Restructuring and other charges
Operating income
% of revenue12.1%10.8%7.6%11.1%
Interest expense
Investment income
Equity method loss, net
Other, net
Earnings from operations before income taxes
Provision for income taxes
Net earnings
% of revenue8.0%7.9%4.7%7.3%
Less: Net earnings attributable to the noncontrolling interest
Net earnings attributable to Labcorp Holdings Inc.
% of revenue8.0%7.9%4.7%7.3%
Basic earnings per share (in dollars per share)—
Diluted earnings per share (in dollars per share)—